Febantel, Praziquantel, Pyrantel Pamoate

Verify with FDA CVM →

169 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
169
Total Reports
6
Deaths Reported
360.0%
Death Rate

Active Ingredients

Febantel, Praziquantel, Pyrantel Pamoate

Administration Routes

OralUnknownTopical

Species Affected

Dog 154
Unknown 13
Cat 2

Most Affected Breeds

Crossbred Canine/dog 35
Unknown 13
Retriever - Labrador 13
Shepherd Dog - German 10
Dog (unknown) 9
Terrier - Yorkshire 8
Setter - English 5
Chihuahua 5
Maltese 5
Retriever - Golden 4

Most Reported Reactions

Vomiting 111
Depression 17
Diarrhoea 16
Hyperactivity 15
Tablets, Abnormal 11
Restlessness 9
Pacing 9
Anorexia 9
Hypersalivation 8
Pruritus 6
Vocalisation 5
Pale mucous membrane 4

Outcome Breakdown

Died
6 (75.0%)
Outcome Unknown
2 (25.0%)

Data Summary

Metric Value
Total adverse event reports 169
Reports involving death 6
Case-fatality rate (reported events) 360.0%
Distinct species in reports 3
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Febantel, Praziquantel, Pyrantel Pamoate Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 169 adverse event reports referencing Febantel, Praziquantel, Pyrantel Pamoate, including 6 reports in which the animal died — a 360.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Febantel, Praziquantel, Pyrantel Pamoate. Reported administration routes include Oral, Unknown, Topical. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Febantel, Praziquantel, Pyrantel Pamoate reports are Dog (154 reports), Unknown (13 reports), Cat (2 reports), with Dog accounting for the largest share. Within those species, Crossbred Canine/dog (35), Unknown (13), Retriever - Labrador (13) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Febantel, Praziquantel, Pyrantel Pamoate are Vomiting (111), Depression (17), Diarrhoea (16), Hyperactivity (15). Of the 8 reports with a coded outcome, Died is the leading category at 75.0%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Febantel, Praziquantel, Pyrantel Pamoate.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial